Clinical Trials Directory

Trials / Unknown

UnknownNCT01779583

Circulating Exosomes As Potential Prognostic And Predictive Biomarkers In Advanced Gastric Cancer Patients ("EXO-PPP Study")

Circulating Exosomes As Potential Prognostic And Predictive Biomarkers In Advanced Gastric Cancer Patients: A Prospective Observational Study ("EXO-PPP Study")

Status
Unknown
Phase
Study type
Observational
Enrollment
80 (estimated)
Sponsor
Hospital Miguel Servet · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Exosomes are formed by inward budding of late endosomes, producing multivesicular bodies (MVBs), and are released into the environment by fusion of the MVBs with the plasma membrane. It has been demonstrated that the content and function of exosomes depends on the originating cell and the conditions under which they are produced. Tumor exosome production, transfer and education of bone marrow cells supports tumor growth and metastasis. In this prospective translational study, preclinical and clinical phases have been designed. On the first step, the main goal is to characterize the molecular profile of gastric cancer derived exosomes. This exosome biosignature may provide a useful diagnostic tool. As a second step, the study will evaluate the prognostic and predictive value of gastric cancer exosomes levels in plasma and kinetics in a prospectively recruited cohort of advanced gastric cancer patients during first-line chemotherapy.

Conditions

Timeline

Start date
2013-01-01
Primary completion
2016-01-01
First posted
2013-01-30
Last updated
2015-03-25

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT01779583. Inclusion in this directory is not an endorsement.

Circulating Exosomes As Potential Prognostic And Predictive Biomarkers In Advanced Gastric Cancer Patients ("EXO-PPP Stu (NCT01779583) · Clinical Trials Directory